BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Dihydroxyphenylalanine

A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.

300+ PubMed studies analyzed · 1 RCTs · Evidence Score: 44.4

Research Domains

Dihydroxyphenylalanine has been studied across 16 research domains including 🧠 Focus & Attention, 🌤️ Mood & Depression, 🧠 Neuroprotection, 🫘 Kidney, 🫁 Liver & Detox. The primary research focus is 🧠 Focus & Attention with 31% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dihydroxyphenylalanine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Trapidil
2 shared targets
juglone
7 shared targets
Catechin
4 shared targets
Carbidopa
3 shared targets
Fusaric
4 shared targets
ethopropazine
4 shared targets
Estramustine
3 shared targets
Evans
3 shared targets
Riboflavin
4 shared targets
Carmine
3 shared targets
Loading evidence profile...

This evidence profile for Dihydroxyphenylalanine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.